Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Colloid and Interface Science|December 19, 2006
Surface properties of kaolin and illite suspensions in concentrated calcium hydroxide mediumKoffi Léon Konan, Claire Peyratout, Jean-Pierre Bonnet, et al.
Journal of Colloid and Interface Science|January 11, 2014
Structural and microstructural studies of montmorillonite-based multilayer nanocompositesDavid Kpogbémabou, Fayza Gridi-Bennadji, Lê Chiên Hoang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust miteAlain Jacquet, Jean-François Vanderschrick, Michel Vandenbranden, et al.
Parasitology Research|January 18, 2006
Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCRPierre Flori, Laëtitia Tardy, Alain Jacquet, et al.
Advances in Medical Sciences|June 1, 2020
Sensitization to major Dermatophagoides pteronyssinus allergens in house dust mite allergic patients from North Eastern Poland developing rhinitis or asthmaKrzysztof Kowal, Agnieszka Pampuch, Grzegorz Siergiejko, et al.
Thrombosis Research|November 30, 2004
Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trialAnwar Umar, Fanny Depont, Alain Jacquet, et al.
The Journal of Allergy and Clinical Immunology|January 21, 2009
A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccinesDavid Walgraffe, Christel Mattéotti, Mohamed El Bakkoury, et al.
Vaccines|September 5, 2020
A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21Teerasit Techawiwattanaboon, Christophe Barnier-Quer, Tanapat Palaga, et al.
Vaccine|February 23, 2002
Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivationAlain Jacquet, Michèle Haumont, Marc Massaer, et al.
Anticancer Research|August 28, 2004
Pre-clinical immunogenicity and anti-tumour efficacy of a deleted recombinant human papillomavirus type 16 E7 proteinSophie Hallez, Jean-Marc Brulet, Caroline Vandooren, et al.
Pageof 7